174 related articles for article (PubMed ID: 28885360)
1. The prognostic value and potential drug target of phosphatase and tensin homolog in breast cancer patients: A meta-analysis.
Xu F; Zhang C; Cui J; Liu J; Li J; Jiang H
Medicine (Baltimore); 2017 Sep; 96(36):e8000. PubMed ID: 28885360
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Mucin Antigen MUC1 in Various Human Epithelial Cancers: A Meta-Analysis.
Xu F; Liu F; Zhao H; An G; Feng G
Medicine (Baltimore); 2015 Dec; 94(50):e2286. PubMed ID: 26683959
[TBL] [Abstract][Full Text] [Related]
3. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.
Li S; Shen Y; Wang M; Yang J; Lv M; Li P; Chen Z; Yang J
Oncotarget; 2017 May; 8(19):32043-32054. PubMed ID: 28410191
[TBL] [Abstract][Full Text] [Related]
4. The predictive role of phosphatase and tensin homolog (PTEN) loss, phosphoinositol-3 (PI3) kinase (PIK3CA) mutation, and PI3K pathway activation in sensitivity to trastuzumab in HER2-positive breast cancer: a meta-analysis.
Wang Y; Liu Y; Du Y; Yin W; Lu J
Curr Med Res Opin; 2013 Jun; 29(6):633-42. PubMed ID: 23574264
[TBL] [Abstract][Full Text] [Related]
5. Association between PTEN and clinical-pathological features of osteosarcoma.
Zhou J; Xiao X; Wang W; Luo Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31270249
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic significance of FOXP3+ tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysis.
Jiang D; Gao Z; Cai Z; Wang M; He J
BMC Cancer; 2015 Oct; 15():727. PubMed ID: 26475790
[TBL] [Abstract][Full Text] [Related]
7. Phosphatase and tensin homolog protein may be linked to lymph node metastasis and tumor node metastasis staging in nonsmall cell lung cancer.
Ji ZY; Li HF; Lei Y; Rao YW; Sun ML; Wang XW; Zhang YL
J Cancer Res Ther; 2018; 14(Supplement):S138-S144. PubMed ID: 29578164
[TBL] [Abstract][Full Text] [Related]
8. Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: A systematic review and meta-analysis.
Tang L; Li X; Gao Y; Chen L; Gu L; Chen J; Lyu X; Zhang Y; Zhang X
PLoS One; 2017; 12(7):e0179437. PubMed ID: 28672019
[TBL] [Abstract][Full Text] [Related]
9. Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status.
Nuciforo PG; Aura C; Holmes E; Prudkin L; Jimenez J; Martinez P; Ameels H; de la Peña L; Ellis C; Eidtmann H; Piccart-Gebhart MJ; Scaltriti M; Baselga J
Ann Oncol; 2015 Jul; 26(7):1494-500. PubMed ID: 25851628
[TBL] [Abstract][Full Text] [Related]
10. The association between phosphatase and tensin homolog hypermethylation and patients with breast cancer, a meta-analysis and literature review.
Lu YM; Cheng F; Teng LS
Sci Rep; 2016 Sep; 6():32723. PubMed ID: 27620353
[TBL] [Abstract][Full Text] [Related]
11. PTEN in kidney cancer: A review and meta-analysis.
Que WC; Qiu HQ; Cheng Y; Liu MB; Wu CY
Clin Chim Acta; 2018 May; 480():92-98. PubMed ID: 29408173
[TBL] [Abstract][Full Text] [Related]
12. Opposite Prognostic Impact of Single PTEN-loss and
Lazaridis G; Kotoula V; Vrettou E; Kostopoulos I; Manousou K; Papadopoulou K; Giannoulatou E; Bobos M; Sotiropoulou M; Pentheroudakis G; Efstratiou I; Papoudou-Bai A; Psyrri A; Christodoulou C; Gogas H; Koutras A; Timotheadou E; Pectasides D; Zagouri F; Fountzilas G
Cancer Genomics Proteomics; 2019; 16(3):195-206. PubMed ID: 31018950
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis.
Xu F; Li M; Zhang C; Cui J; Liu J; Li J; Jiang H
Oncotarget; 2017 Jan; 8(4):6003-6012. PubMed ID: 27999206
[TBL] [Abstract][Full Text] [Related]
14. PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases.
Wang LL; Hao S; Zhang S; Guo LJ; Hu CY; Zhang G; Gao B; Zhao JJ; Jiang Y; Tian WG; Wang J; Luo DL
Hum Pathol; 2017 Mar; 61():49-57. PubMed ID: 27864123
[TBL] [Abstract][Full Text] [Related]
15. The association of PTEN hypermethylation and breast cancer: a meta-analysis.
Luo S; Chen J; Mo X
Onco Targets Ther; 2016; 9():5643-50. PubMed ID: 27672335
[TBL] [Abstract][Full Text] [Related]
16. Loss of phosphatase and tensin homolog expression correlates with clinicopathological features of non-small cell lung cancer patients and its impact on survival: A systematic review and meta-analysis.
Zhao Y; Zheng R; Li J; Lin F; Liu L
Thorac Cancer; 2017 May; 8(3):203-213. PubMed ID: 28263037
[TBL] [Abstract][Full Text] [Related]
17. Tau and PTEN status as predictive markers for response to trastuzumab and paclitaxel in patients with HER2-positive breast cancer.
Koo DH; Lee HJ; Ahn JH; Yoon DH; Kim SB; Gong G; Son BH; Ahn SH; Jung KH
Tumour Biol; 2015 Aug; 36(8):5865-71. PubMed ID: 25725586
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.
Huang R; Ding P; Yang F
Drug Des Devel Ther; 2015; 9():5277-85. PubMed ID: 26425077
[TBL] [Abstract][Full Text] [Related]
19. Loss of Expression of PTEN is Associated with Worse Prognosis in Patients with Cancer.
Qiu ZX; Zhao S; Li L; Li WM
Asian Pac J Cancer Prev; 2015; 16(11):4691-8. PubMed ID: 26107225
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S
PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]